Oura and Counsel Health Expand Partnership Through CMS ACCESS Model

The intersection of wearable technology and government-backed healthcare delivery reached a significant milestone today as smart-ring manufacturer Oura announced an expanded partnership with AI-native primary care company Counsel. The collaboration is designed to leverage the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s newly established Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. This large-scale initiative aims to integrate continuous biometric data streams with proactive, physician-led clinical interventions to better support aging Americans managing prevalent, complex health conditions.

Beginning in early 2027, Counsel will roll out an advanced suite of AI-native chronic care services targeting conditions such as hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, these comprehensive medical services will be made available at no out-of-pocket cost to eligible Medicare beneficiaries spanning nearly all United States jurisdictions. By marrying the real-time health metrics captured by the Oura Ring with Counsel’s board-certified medical staff and diagnostic artificial intelligence, the initiative hopes to establish a replicable blueprint for modern, preventive care within public healthcare frameworks.

The Evolution of Wearables in Clinical Practice

To understand the weight of this announcement, one must look back at the trajectory of digital health over the past decade. Wearable devices like smartwatches and fitness rings transitioned rapidly from novelty step-counters into sophisticated physiological monitoring tools capable of tracking heart rate variability, skin temperature, sleep architecture, and blood oxygen saturation. However, a persistent challenge for consumers and clinicians alike has been the "last mile" problem: translating raw data dashboards into actionable clinical insights.

Recognizing this gap, Oura and Counsel initially forged a commercial partnership in May of this year. That foundational alliance was engineered to help Oura members effortlessly transition from passive health monitoring to active clinician engagement. The positive reception of that initial integration—evidenced by high patient satisfaction scores where members utilizing the service rated their physician interactions an impressive 4.6 out of 5—paved the way for the current scale-up under the CMS ACCESS Model.

While the initial integration served a general consumer base, the newly announced phase specifically targets the Medicare demographic. This population frequently carries the heaviest burden of chronic illnesses, which account for the vast majority of national healthcare expenditures. Through the ACCESS program, the partnership is no longer just an optional wellness add-on; it becomes a formalized, studied healthcare delivery model operating within the parameters of federal health innovation initiatives.

Mechanics of the Model: AI, Biometrics, and Human Expertise

The operational framework of the Oura-Counsel initiative relies on a symbiotic relationship between advanced software algorithms and licensed medical professionals. Counsel’s proprietary medical AI acts as an initial triage and analytical layer, continuously scanning incoming health data for anomalous trends or indicators of clinical decline. When intervention is warranted, on-demand access to board-certified physicians is triggered, allowing patients to receive timely consultations without the traditional friction of scheduling delays or physical office visits.

For participants who wear the Oura Ring and explicitly consent to data-sharing protocols, the diagnostic picture becomes vastly more granular. Instead of relying on episodic measurements taken during a semi-annual doctor’s visit—which often fail to capture white-coat hypertension or fluctuating glucose levels—clinicians will review continuous longitudinal trends. This persistent data stream allows medical providers to observe how lifestyle modifications, medication adjustments, or environmental stressors impact a patient’s physiology over days, weeks, and months.

Dr. Ricky Bloomfield, Chief Medical Officer at Oura, emphasized the significance of this scale-up in a statement reflecting on the partnership’s evolution. "Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," Dr. Bloomfield noted. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

Demographics and the Target Population

The strategic focus on cardio-kidney-metabolic conditions—specifically hypertension, obesity, hyperlipidemia, and prediabetes—is underpinned by robust demographic data within Oura’s existing user base. Countering the assumption that wearable technology is the exclusive domain of younger demographics, Oura reports that members aged 65 and older represent one of its most consistently engaged cohorts, exhibiting exceptionally high daily application interaction rates.

Furthermore, internal data reveals that approximately 20 percent of Oura members within this senior demographic present with a Body Mass Index (BMI) of 30 or higher, placing them squarely in the category where proactive obesity management and lifestyle intervention can drastically alter long-term health trajectories. By deploying the ACCESS program to this highly engaged yet vulnerable group, the partnership addresses a critical juncture where continuous monitoring can prevent acute medical crises, such as myocardial infarctions or strokes, before they occur.

Chronology of the Collaboration

The roadmap leading to the 2027 rollout reflects a deliberate, phased approach to integrating consumer hardware with institutional healthcare compliance:

• May: Oura and Counsel announce their initial commercial partnership, bridging the gap between passive Oura App health insights and on-demand clinician actions. Initial user metrics demonstrate high satisfaction, with physician consultations averaging a 4.6 out of 5 rating.
• Fall: Following the success of the initial integration, both organizations align their strategies with the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s ACCESS Model framework.
• Today: Oura formally announces the expanded partnership, committing to support Counsel’s deployment of AI-native chronic care for Medicare beneficiaries starting in early 2027.
• Late 2026 / Early 2027: The Oura App begins rolling out informational and enrollment pathways to connect interested senior members with Counsel, pending individual clinical eligibility screenings.

Broader Implications for the Healthcare Landscape

The inclusion of consumer health technology companies in a CMS Innovation Center model signals a potential paradigm shift in how the federal government views preventative medicine and digital health tools. Historically, federal healthcare programs have maintained strict boundaries around proprietary consumer hardware, often requiring specialized, FDA-cleared medical devices for reimbursement and structured clinical studies.

By participating in the ACCESS Model, Oura and Counsel are positioned to generate real-world evidence (RWE) on a massive scale. If the study demonstrates that continuous biometric tracking paired with AI-driven, on-demand primary care can meaningfully improve health outcomes while lowering systemic costs for conditions like hypertension and prediabetes, it could serve as a powerful precedent for future CMS policies. Such a shift might eventually broaden insurance coverage parameters to include consumer-grade wellness hardware, provided they are tied to accredited clinical networks.

For patients, the model promises a consumer-grade experience applied to clinical-grade care. Navigating the Medicare system can often feel fragmented, reactive, and bureaucratic. By embedding proactive monitoring into daily routines—such as wearing a ring that is already integrated into a user’s morning and evening habits—the friction of healthcare compliance is dramatically reduced.

Enrollment Pathways and Next Steps

As the 2027 launch date approaches, operational details regarding the onboarding process are beginning to take shape. Oura will utilize its existing software ecosystem—primarily the Oura App—to serve as an informational bridge. Members who meet the age requirements and express interest in the ACCESS program will be introduced to Counsel’s intake workflows.

However, utilization of the program will maintain rigorous clinical standards. Counsel will independently manage the formal clinical eligibility verification process, ensuring that participating beneficiaries meet the strict medical criteria established by the CMS ACCESS Model guidelines. Counsel will subsequently oversee all aspects of care delivery, patient management, and ongoing treatment plans.

Comprehensive details concerning specific eligibility questionnaires, regional availability specifics within the United States, and step-by-step app integration guides will be released by Oura and Counsel in the months leading up to the 2027 launch. As the healthcare sector watches closely, this partnership may well redefine the boundaries of proactive medicine, proving that the future of chronic disease management lies in the seamless fusion of continuous data, intelligent software, and dedicated human care.